Schoenberg Mark sold URGN
August 11, 2025 · Form 4 insider transaction
Schoenberg Mark sold 10,000 shares of UroGen Pharma Ltd. at $17.69 per share, a transaction worth $176.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
10,000
Price
$17.69
Total value
$176.9K
InsiderSchoenberg Mark
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateAugust 11, 2025
Filing dateAugust 13, 2025
Shares owned after148,229
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 and $17.76. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.